Non-motor symptoms (NMS) improvement is positively correlated with baseline NMS burden and improved quality of life in advanced Parkinson's disease patients treated with levodopa-carbidopa intestinal gel: a post-hoc analysis from the GLORIA registry

被引：0
|
作者：
Poewe, W. [1 ]
Bergmann, L. [2 ]
Antonini, A. [3 ]
Chaudhuri, K. R. [4 ,5 ]
机构：
[1] Med Univ Innsbruck, Innsbruck, Austria
[2] AbbVie Inc, N Chicago, IL USA
[3] Univ Padua, Dept Neurosci, Padua, Italy
[4] Kings Coll London, London, England
[5] Kings Coll Hosp London, London, England
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR3072
引用
收藏
页码：518 / 519
页数：2
相关论文
共 50 条
  • [41] Sustained improvements in motor and non-motor symptoms in advanced Parkinson's disease patients treated with carbidopa levodopa enteral suspension in a 'real-world' study
    Chaudhuri, K. Ray
    Aldred, Jason
    Standaert, David
    Kovacs, Norbert
    Pontieri, Francesco
    Bourgeois, Paul
    Davis, Thomas
    Cubo, Esther
    Anca-Herschkovitsch, Marieta
    Iansek, Robert
    Siddiqui, Mustafa
    Simu, Mihaela
    Bergmann, Lars
    Kukreja, Pavnit
    Robieson, Weining
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 328 - 328
  • [42] Motor outcomes in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study
    Leonardo Lopiano
    Nicola Modugno
    Pietro Marano
    Mariachiara Sensi
    Giuseppe Meco
    Antonino Cannas
    Graziano Gusmaroli
    Filippo Tamma
    Francesca Mancini
    Rocco Quatrale
    Anna Maria Costanzo
    Giuliana Gualberti
    Gabriella Melzi
    Umberto di Luzio Paparatti
    Angelo Antonini
    Neurological Sciences, 2016, 37 : 1785 - 1792
  • [43] Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study
    Lopiano, Leonardo
    Modugno, Nicola
    Marano, Pietro
    Sensi, Mariachiara
    Meco, Giuseppe
    Cannas, Antonino
    Gusmaroli, Graziano
    Tamma, Filippo
    Mancini, Francesca
    Quatrale, Rocco
    Costanzo, Anna Maria
    Gualberti, Giuliana
    Melzi, Gabriella
    Paparatti, Umberto di Luzio
    Antonini, Angelo
    NEUROLOGICAL SCIENCES, 2016, 37 (11) : 1785 - 1792
  • [44] Non-motor symptoms before and 3 months after deep brain stimulation and continuous infusion of levodopa-carbidopa intestinal therapy in patients with advance Parkinson's disease
    Vuletic, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 851 - 851
  • [45] Efficacy and safety of levodopa-carbidopa intestinal gel in patients with less than 10 years of Parkinson's disease - Interim results from the GLORIA long-term registry
    Antonini, A.
    Chaudhuri, K. R.
    Bergmann, L.
    Yegin, A.
    Onuk, K.
    Poewe, W.
    MOVEMENT DISORDERS, 2015, 30 : S67 - S67
  • [46] Rationale and Design of an Open-Label, Randomized, 26-Week Study Comparing Levodopa-Carbidopa Intestinal Gel to Optimized Medical Treatment on Non-Motor Symptoms in Patients with Advanced Parkinson's Disease - INSIGHTS Study
    Chaudhuri, K. Ray
    Weintraub, Daniel
    Antonini, Angelo
    Robieson, Weining Z.
    Li, Mei
    Chatamra, Krai
    Benesh, Janet
    Facheris, Maurizio F.
    MOVEMENT DISORDERS, 2018, 33 : S90 - S90
  • [47] Rationale and Design of an Open-Label, Randomized, 26-Week Study Comparing Levodopa-Carbidopa Intestinal Gel to Optimized Medical Treatment on Non-Motor Symptoms in Patients with Advanced Parkinson's Disease - INSIGHTS Study
    Chaudhuri, K. Ray
    Weintraub, D.
    Antonini, A.
    Robieson, W.
    Li, M.
    Chatamra, K.
    Benesh, J.
    Facheris, M.
    MOVEMENT DISORDERS, 2018, 33 : S198 - S198
  • [48] Levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations: Interim quality-of-life endpoints in an ongoing, open-label study
    Standaert, D. G.
    Fernandez, H. H.
    Odin, P.
    Hauser, R. A.
    Espay, A. J.
    Hass, S.
    Robieson, W. Z.
    Widnell, K. L.
    Chatamra, K.
    Benesh, J.
    MOVEMENT DISORDERS, 2012, 27 : S140 - S140
  • [49] Application of the "5-2-1" Screening Criteria in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study
    Antonini, A.
    Aldred, J.
    Bergmann, L.
    Kovacs, N.
    Kukreja, P.
    Robieson, W.
    Standaert, D.
    Chaudhuri, K. R.
    MOVEMENT DISORDERS, 2019, 34 : S25 - S26
  • [50] Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson's Disease
    Szasz, Jozsef Attila
    Constantin, Viorelia Adelina
    Orban-Kis, Karoly
    Bancu, Ligia Ariana
    Ciorba, Marius
    Mihaly, Istvan
    Nagy, Elod Erno
    Szasz, Robert Mate
    Kelemen, Krisztina
    Simu, Mihaela Adriana
    Szatmari, Szabolcs
    BRAIN SCIENCES, 2021, 11 (07)
12345